Podcasts about Lipoprotein

When it comes to assessing your cardiovascular risk, your blood tells an eloquent story. It's not just cholesterol but several other factors that can be detected and measured that point toward or away from risk. Roger Blumenthal, a cardiologist at … What does a blood marker called lipoprotein A have to do with your risk for cardiovascular disease? Elizabeth Tracey reports Read More »

Lipoprotein (a) (Lp(a)) was discovered in 1963 by a Norwegian geneticist by the name of Kåre Berg who studied particles that carried cholesterol in the blood. He found some patients had an additional protein on the low-density lipoprotein. Studies found that patients with elevated Lp(a) had increased risks of cardiovascular disease. However, the levels were not affected by diet, environmental factors, or medications. The result is that this test was largely ignored for the last few decades. Recent dyslipidaemia guidelines released by the United States and Europe have returned a focus back on to Lp(a). They recommend that patients should have Lp(a) tested once throughout their life to assess their cardiovascular disease risk. The result can help identify which patients are at a higher risk of cardiovascular morbidity and mortality and who will benefit from lifestyle modification and early intervention. This resource is referenced during the discussion: https://www.lpaclinicalguidance.com/ This is the story of lipoprotein (a). Our Special Guests: Dr Michael Page is a chemical pathologist at Clinipath in Perth, senior lecturer at the UWA Medical School, and immediate past President of the AMA (WA). Listen: This Medical Life podcast is available on all podcasting services and Spotify. Members of the RACGP are able to log the hours as CPD (Education) that they listen to the episodes under self record via Quick log. We invite you to help support us on our donation page.See omnystudio.com/listener for privacy information.

Show Notes HOST Melody Hartzler | | Book Appointment AROUND THE TABLE Joel Kahn | | Visit Website In Today's Episode Preventive cardiologist Dr. Joel Kahn joins Melody Hartzler on this episode of Table Talk to break down how lifestyle changes, nutrition, and advanced diagnostic testing can protect your heart. Dr. Kahn shares his journey from traditional interventional cardiology to preventive care and explains how inflammation, diet, hormone changes, and personalized risk assessments can help identify cardiovascular issues before they become serious. Key Take Aways Heart disease prevention starts with understanding individual risk factors, including inflammation, family history, metabolic health, and lifestyle habits. Advanced testing such as coronary artery calcium scans, carotid ultrasounds, and inflammatory markers can provide a more complete picture of cardiovascular risk. Whole-food, plant-based nutrition remains one of the most powerful tools for preventing and even reversing heart disease. Lipoprotein(a) is an often-overlooked genetic risk factor that can significantly impact cardiovascular health, especially in women. Lifestyle changes—including nutrition, exercise, stress management, sleep, and weight management—should be the foundation of any heart health plan before considering more aggressive interventions. Topics Discussed 00:00 – Welcome to Table Talk Melody Hartzler introduces today's guest, preventive cardiologist Dr. Joel Kahn, and previews the discussion on heart disease prevention and functional medicine. 01:06 – Dr. Kahn's Journey to Preventive Cardiology Dr. Kahn shares how his experience in traditional cardiology led him to focus on preventing heart disease through lifestyle and nutrition. 03:00 – The Impact of Plant-Based Nutrition How nutrition transformed Dr. Kahn's approach to patient care and cardiovascular health. 04:15 – A Common Patient Scenario Discussing women approaching menopause and the cardiovascular changes that often emerge during this stage of life. 05:27 – Looking Beyond Standard Labs The importance of comprehensive cardiovascular assessments, lifestyle factors, and personalized risk evaluation. 06:00 – Understanding Inflammation and Heart Disease Key inflammatory markers and why inflammation plays a central role in cardiovascular health. 07:24 – Omega-3 Testing and Nutritional Strategies How omega-3 levels and targeted nutrition can support heart health and reduce risk. 07:41 – Measuring Arterial Health Using carotid ultrasounds and artery age assessments to detect cardiovascular issues early. 08:39 – Coronary Artery Calcium Scans Explained Who should consider a calcium scan and how it helps identify hidden heart disease risk. 09:51 – Interpreting Calcium Scores What different calcium scores mean and when intervention may be necessary. 11:37 – Advanced Cardiovascular Testing Exploring inflammatory markers, metabolic indicators, and additional tools for risk assessment. 12:38 – The Importance of Lipoprotein(a) Understanding this genetic risk factor and its role in cardiovascular disease. 14:00 – Supplements for Heart Health A discussion on red yeast rice, omega-3s, berberine, and other commonly used supplements. 15:31 – Niacin and Cholesterol Management When niacin may be helpful and how it fits into a cardiovascular prevention plan. 17:02 – Choosing Quality Supplements What to look for when selecting supplements and why quality matters. 19:00 – Red Yeast Rice vs. Statins Comparing natural and pharmaceutical approaches to cholesterol management. 20:00 – Statins, Side Effects, and CoQ10 Addressing common concerns and discussing strategies to support patients using statins. 24:00 – Is a Plant-Based Diet Necessary? Dr. Kahn shares his perspective on nutrition and individualized approaches to heart health. 26:00 – AGEs and Cooking Methods How advanced glycation end products affect cardiovascular health and practical ways to reduce exposure. 27:49 – Resources and Where to Find Dr. Kahn Dr. Kahn shares where listeners can learn more about his work and access additional resources. 28:18 – Final Thoughts and Closing Remarks Key takeaways from the conversation and a wrap-up of the episode. Resources Mentioned Table Talk Podcast — Resources & Links The PharmToTable Team – Functional Medicine Providers Therapies & Approaches Discussed: Preventive Cardiology Functional Medicine Plant-Based Nutrition Lifestyle Medicine Inflammation Reduction Hormone Replacement Therapy (HRT) Tests & Biomarkers Discussed: Coronary Artery Calcium (CAC) Scan Carotid Artery Ultrasound Lipoprotein(a) [Lp(a)] High-Sensitivity C-Reactive Protein (hs-CRP) Omega-3 Testing Supplements Discussed: Berberine Niacin (Vitamin B3) Endur-Acin® CoQ10 (Coenzyme Q10) Supplement Spotlight Vitamin D / K2 Liquid - 1 fl oz Purchase Today D3 5000 with K2 60 Softgels Purchase Today

Cholesterinwerte zu hoch – Statin nehmen – Problem erledigt? So einfach ist es leider oft nicht. Das liegt unter anderem daran, dass Betroffenen oft unklar ist, was genau damit erreicht werden kann und soll. Zudem sorgen häufig Begriffe wie LDL-Zielwert, Non-HDL, Apolipoprotein B und Lipoprotein (a) – kurz Lp(a) – für Vewirrung. Im Podcastgespräch mit Professor Ulrich Laufs aus Leipzig ordnen wir diese Begriff alltagstauglich ein. Außerdem erfahren Sie, welche neuen Wirkstoffe vielleicht schon in naher Zukunft die Therapie zu hoher Blutfettwerte verbessern könnten. Hören Sie rein in ein spannendes Update zum Thema Cholesterin.

Das weibliche Herz. Unsere Hormone. Und die große Frage: Wie bleiben wir möglichst gesund – bis ins hohe Alter? In dieser Folge bekommt ihr nicht nur Antworten, sondern echtes Aha-Wissen. Eins ist klar: Unsere Herzgesundheit verdient gerade in den Wechseljahren unsere volle Aufmerksamkeit. Seit mehr als zweieinhalb Jahren sprechen Host Katrin Simonsen und Hormonexpertin Dr. Katrin Schaudig im Podcast "Hormongesteuert" über die Wechseljahre. Und immer wieder sorgen Gäste für Überraschungen – mit neuen Studien, spannenden Erkenntnissen und Fakten, die man so noch nicht gehört hat. Diese Folge ist deshalb ein echtes Must Listen für alle Frauen. Denn unser Herz ist der Schlüssel dazu, wie wir altern – und wie hoch unser Risiko für einen Herzinfarkt ist. Und trotzdem wissen viele Frauen viel zu wenig darüber, was in ihrem Körper wirklich passiert. Mit dabei: Prof. Sandra Eifert, Herzexpertin und Gendermedizinerin vom Herzzentrum Leipzig. Sie nimmt uns mit in die Welt unseres Herz-Kreislauf-Systems – und erklärt, warum gerade Frauen genauer hinschauen sollten. Darum geht es: Warum der Blutdruck alles andere als konstant ist. Was Wut, Stress, Kaffee – und sogar Tee – damit machen. Und warum es manchmal gesünder ist, negative Gefühle rauszulassen, statt sie runterzuschlucken. Wir sprechen darüber, was Stress in Hirn und Gefäßen wirklich anrichtet. Und warum er für Frauen oft besonders gefährlich ist. Außerdem gibt es neue medizinische Entwicklungen, die Hoffnung machen – zum Beispiel für Frauen mit erhöhtem Lipoprotein(a). Außerdem: Was die Augengesundheit über die Gefäße verrät – und warum Bluthochdruck dabei eine entscheidende Rolle spielt. Links - Hormongesteuert zum Nachlesen https://www.mdr.de/barrierefreiheit/podcast-nachlesen/hormongesteuert/alle-folgen-podcast-hormongesteuert-textversion-100.html - Hormongesteuert #13: Wenn das Herz in die Wechseljahre kommt - https://www.ardsounds.de/episode/urn:ard:episode:d52ca027a23b8fe6/ - Podcast-Tipp: Die ErnährungsDocs - Essen als Medizin - https://1.ard.de/Ernaehrungs-Docs_Podcast Feedback und Anregungen gern an hormongesteuert@mdraktuell.de Inhaltsverzeichnis: 0:02:20 Warum steigt bei den Frauen der Blutdruck? 0:05:10 Blutdruck schwankt im Tagesverlauf – aber wann muss man reagieren? 0:10:40 Hörerinfrage: Perimenopause und schwankender Blutdruck 0:14:30 Gestagen Drospirenon wirkt entwässernd und kann helfen 0:15:30 Hörerinnenfragen zur Hormontherapie und Bluthochdruck 0:23:10 Welche Blutdruckmedikamente werden gern eingesetzt? 0:25:10 Betablocker für Frauen manchmal sogar gefährlich 0:28:50 Studie: Frauenherzen reagieren stärker auf Stress 0:36:20 Hörerinfrage: Erhöhter Puls und Herzstolperer 0:42:20 Welche Mineralstoffe und Vitamine fürs Herz? 0:44:00 Hörerinfrage: Gestagenpille und Herzrasen 0:45:30 Bei erhöhtem Herzschlag auch Ferritin-Speicher messen 0:47:20 Viele Fragen rund um das Lipoprotein(a) 0:53:30 Hormongabe trotz vorhandener Plaques? 1:03:50 Autoimmunerkrankungen erhöhen unser Herz-Kreislaufrisiko 1:08:20 Mikrozirkulationsstörung und Makuladegeneration

Lp(a) affects 25% of people, increases heart attack and stroke risk, and is rarely tested—Dr. Kahn urges early detection. #Lp(a) #CardiacRisk #EarlyScreening #SilentKiller

Lipoprotein(a) or Lp(a) is suddenly all the rage because several drug companies are working on medications to lower this previously resistant form of cholesterol. Almost entirely genetic, unaffected by diet or lifestyle, it has numerous studies linking it to heart disease and aortic valve calcification. But it may not be the ticking time bomb some influencers like to claim.   Become a supporter of our show today either on Patreon or through PayPal! Thank you! http://www.patreon.com/thebodyofevidence/ https://www.paypal.com/donate?hosted_button_id=9QZET78JZWCZE   Email us your questions at thebodyofevidence@gmail.com.   Editor:    Robyn Flynn Theme music: “Fall of the Ocean Queen“ by Joseph Hackl Rod of Asclepius designed by Kamil J. Przybos Chris' book, Does Coffee Cause Cancer?: https://ecwpress.com/products/does-coffee-cause-cancer   Obviously, Chris is not your doctor (probably). This podcast is not medical advice for you; it is what we call information. References: The genetic nature of Lp(a) levels: https://pubmed.ncbi.nlm.nih.gov/1386087/ Prevalence of elevated Lp(a) in 500,000 US patients https://pubmed.ncbi.nlm.nih.gov/27659098/ Prevalence of elevated Lp(a) in 2.9 million Chinese adults https://pubmed.ncbi.nlm.nih.gov/40266173/ Prevalence of elevated Lp(a) in the INTERASPIRE study https://pubmed.ncbi.nlm.nih.gov/40436467/ Variation of Lp(a) by sex: https://pubmed.ncbi.nlm.nih.gov/27659098/ One of the many studies linking Lp(a) to cardiovascular disease https://pubmed.ncbi.nlm.nih.gov/33115266/ High Lp(a) and aortic stenosis: https://www.nejm.org/doi/full/10.1056/NEJMoa1109034 FH and Lp(a) https://pubmed.ncbi.nlm.nih.gov/32466883/ The ongoing Lp(a) trials https://familyheart.org/lpa-clinical-trials  

On today's Good Day Health Show - ON DEMAND…Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken begin with what yoga can do for your heart. Yoga improves heart health by lowering blood pressure, reducing stress, decreasing heart rate, and improving cholesterol levels, often as effectively as conventional exercise. Regular practice, including poses like Downward Dog and Tadasana (Mountain Pose), boosts circulation, reduces inflammation, and strengthens the cardiovascular system.Moving on to weight loss drugs, the weight-loss drug market is shifting toward oral, daily pills like Foundayo (orforglipron) and an oral version of Wegovy (semaglutide), following FDA approval in late 2025/early 2026. These new pills, which mimic GLP-1 hormones to curb appetite, saw over 170,000 prescriptions within three weeks of launch. Increased demand has led to a potential price war between major manufacturers Novo Nordisk and Eli Lilly, as well as a rise in state Medicaid coverage. Weight loss drugs like Wegovy and Ozempic (semaglutide) are showing significant health benefits beyond shedding pounds, including a 20% reduction in heart attacks and strokes, improved kidney health, and potential addiction reduction. These drugs, known as GLP-1 receptor agonists, act on the brain to reduce cravings and reduce inflammation.Next up, Doug and Dr. Ken address Lipoprotein(a), commonly referred to as ”L-P-little-A” and abbreviated as Lp(a), is a type of genetically inherited cholesterol particle that carries fat and cholesterol through the blood. High levels of Lp(a) significantly increase the risk of heart attack, stroke, and aortic valve disease because the particles promote plaque buildup, inflammation, and blood clots in arteries Getting your Lipoprotein(a) [Lp(a)] checked via blood test is crucial because it measures a highly genetic, "sticky" form of LDL cholesterol that standard lipid panels miss. High Lp(a) significantly increases the risk of heart disease, stroke, and aortic valve stenosis, making it a critical, independent factor in assessing your overall cardiovascular health. In other news, research and studies on the effects of soccer in youth and why certain precautions need to be addressed. New reviews and studies in 2025 and 2026 indicate that frequent soccer heading is linked to measurable, long-term declines in brain structure and cognitive function, reinforcing the need for stricter rules to protect players from subconcussive injuries. Research has highlighted that repetitive, low-level impacts—not just overt concussions—damage white matter and that rule changes curbing headers are highly effective, prompting calls for broader implementation.Shifting focus, research shows adults experiencing weekly nightmares have up to a threefold higher risk of premature death (before age 70–75) and show signs of faster biological aging. This increased mortality is linked to chronic stress and accelerated cellular aging, potentially acting as a stronger risk factor than smoking or obesity. These nightmare events have your brain believing it's real and triggering real stress responses in your body. A rare nightmare won't effect health, but constant nightmares are something to be addressed. For more on Good Day Health…Website: GoodDayHealthShow.comSocial Media: @GoodDayNetworks

Text Dr. Lenz any feedback or questions Three Blood Tests That Reveal Your True Heart Attack Risk: hsCRP, Lipoprotein(a), and ApoBDr. Michael Lenz argues the standard lipid panel can miss key drivers of atherosclerosis, explaining why some people with “normal” LDL still have heart attacks, and recommends three additional blood tests to better assess risk. High-sensitivity C-reactive protein (hsCRP) measures inflammation, with higher levels indicating increased risk and supported by the JUPITER trial showing benefit of statins in people with normal LDL but elevated hsCRP. Lipoprotein(a) is a largely genetic, “extra dangerous” LDL-related particle linked causally to heart attacks, strokes, and aortic valve disease; a one-time adult test is recommended, especially with early family history, and high levels warrant aggressive control of other risk factors while targeted therapies are in trials. ApoB counts atherogenic particles and may predict risk better than LDL, particularly with insulin resistance or diabetes.00:00 Hidden Heart Attack Risk01:53 Inflammation Fire Alarm03:06 hsCRP Risk Levels04:21 Lipoprotein A Genetics06:08 What to Do If High06:59 ApoB Particle Count08:27 ApoB Targets and Discordance09:23 Putting the Three Together10:17 Final Takeaways and Next Steps Support the showWhen I started this podcast and YouTube Channel—and the book that came before it—I had my patients in mind. Office visits are short, but understanding complex, often misunderstood conditions like fibromyalgia takes time. That's why I created this space: to offer education, validation, and hope.  If you've been told fibromyalgia “isn't real” or that it's “all in your head,” know this—I see you. I believe you. This podcast aims to affirm your experience and explain the science behind it. Whether you live with fibromyalgia, care for someone who does, or are a healthcare professional looking to better support patients, you'll find trusted, evidence-based insights here, drawn from my 29+ years as an MD.Please remember to talk with your doctor about your symptoms and care. This content doesn't replace per...

Darren Ali was a healthy 45 year old when he had a massive heart attack that could have killed him. He wants everyone to learn from his experience and get tested for the cholesterol Lipoprotein(a) because it could save their lives. And we'll hear from a doctor about how this cholesterol can cause unexpected heart attacks among younger and otherwise healthy people -- and why new guidance recommends getting tested.

Cholesterin – nicht oberflächlich, sondern mal verständlich erklärt.

This week, Dr. Kahn discusses his long-standing interest in the amino acid glycine and its potential health benefits. Sleep is a key focus, highlighted by a new report on the widespread difficulty adults face in getting a full night's rest. Glycine may also offer favorable cardiovascular support. Additional topics include coffee and aging, methamphetamines and heart attacks, Lipoprotein(a) and cardiovascular risk, yoga and overall health, a tribute to Eugene Braunwald, MD, TMAO and atherosclerosis, and a new study on the benefits of adopting heart-healthy habits early in life.  Thanks to the Fresh Pressed Olive Oil Club and the special discount offer at getfreshdrkahn.com

What if one simple blood test could reveal a genetic risk factor for heart disease that affects 1 in 5 people worldwide?Rip sits down with physician, endurance athlete, and author Dr. Akil Taher to talk about a critical—but often overlooked—marker for cardiovascular risk: Lipoprotein(a), or Lp(a).Despite decades of research linking elevated Lp(a) to heart attacks, strokes, and aortic valve disease, fewer than 2% of Americans have ever been tested.Dr. Taher shares his remarkable personal story—from heart disease and bypass surgery to becoming a marathoner and mountain climber in his 70s—and explains why understanding your Lp(a) level could be lifesaving.They dive into:What Lp(a) actually is and why it's called the “evil cousin of LDL”Why genetics—not lifestyle—largely determine your Lp(a)Why many healthy people still suffer heart attacksThe surprising link between Lp(a), inflammation, and blood clottingWho should absolutely get testedWhy the nanomoles-per-liter test mattersHow lifestyle medicine and a whole-food plant-based diet still play a critical protective roleDr. Taher's message is simple but powerful:Get tested. Know your number. Protect your heart.Because what you don't know can hurt you—but what you discover could save your life.Episode WebpageWatch the Episode on YouTubeLearn More About our 2026 Live PLANTSTRONG Events: https://plantstrongevents.com/ Let Us Help Your PLANTSTRONG JourneyLearn More About Our Corporate Wellness Program: https://liveplantstrong.com/corporate-wellness/ COMPLEMENT: Use code PLANTSTRONG for 30% off at https://lovecomplement.com/pages/plantstrong-special-offer Follow PLANTSTRONG and Rip Esselstynhttps://plantstrong.com/ https://www.facebook.com/GoPlantstrong https://www.instagram.com/goplantstrong/https://www.instagram.com/ripesselstyn/ Follow the PLANTSTRONG Podcast and Give the Show a 5-star RatingApple PodcastsSpotify

Send us Fan MailPerimenopause and menopause are about more than hot flashes and mood changes—they're also a critical time to assess long-term health risks. In this episode, Dr. Angela explains why cardiovascular disease risk rises during the menopause transition, often silently, and why women should know their blood pressure, cholesterol, ApoB, Lipoprotein(a), and overall metabolic health. She also shares practical prevention steps and why the most important intervention may sometimes be reducing heart attack or stroke risk—not just treating symptoms.Support the showFollow me on Instagram @angelalifestylemd and don't forget to SUBSCRIBE to my podcast & SHARE this episode.

Calcium Score to Evaluate Arterial Plaque; 50% of Statin Candidates May Not Need Them; Cholesterol Skepticism and Misunderstood Risk; Inflammation as a Key Risk Driver; Combining CRP and LDL for Better Risk Prediction; Why ApoB and Lipoprotein(a) Matter More Than LDL; Patient Case: High Lipoprotein(a) Despite Normal Cholesterol; Understanding Supplements: Red Yeast Rice and Berberine; Niacin: The Disappointing Heart Health Supplement; Amla (Indian Gooseberry) and Simvastatin Comparison; Health = Resilience ÷ Stress; Genetic Variability in Cholesterol Absorption from Food #HeartHealth #Cholesterol #LifestyleMedicine #HealthTalks

On today's Good Day Health Show - ON DEMAND… Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken begin with good news that the American survival rate for ALL cancers has reached 5 years. In large part, this is because we're doing better at early diagnosis, we have diagnostic tools we never had before, and there is more of a focus on immune therapy in treating cancers to prevent cancer from progressing/spreading or returning.  Moving on, the conversation shifts to GLP-1s and their effect on diabetes as well as overall weight loss with the help of suppressing appetite. The movement on these medications are progressing from shots to oral pills. While not currently as effective as the shots, the pill form is a good choice for those adverse to injections. When it comes to cholesterol, the numbers per individual have changed over the years with many thinking one set of numbers is considered “good,” when it could be the wrong numbers for that specific person. When it comes to cardiovascular prevention, patients should work with medical professionals who are specialists with cholesterol to determine what their numbers should be. Additionally, how cholesterol numbers affect the heart and why some people look like they are incredibly fit, yet have dangerously high cholesterol. Dr. Ken goes on to say some general guidelines of what he wants a patients LDL to be based on other elevations happening in your body, based on the amount of plaque he sees in coronaries, and even Lipoprotein(a) reference range. For better understanding, Lipoprotein(a) is a genetically determined, cholesterol-carrying particle in the blood that, when elevated, significantly increases the risk of heart disease, stroke, and aortic stenosis. Primarily inherited, high levels are not typically affected by diet or exercise, causing plaque, inflammation, and blood clots.Rounding out the conversation, Doug and Dr. Ken address listener questions. Included in the discussion are questions about exercise, specifically how working out can improve neurological conditions like depression. Another question addresses the new food pyramid, how it's upside down and sifting through the confusion of the change up.Website: GoodDayHealthShow.com Social Media: @GoodDayNetworks

Commentary by Dr. Jian'an Wang.

Commentary by Dr. Jian'an Wang.

Lipids remain central to cardiovascular prevention. The 2026 ACC/AHA Dyslipidemia Guideline introduces several important shifts:   • PREVENT equations replace older ASCVD risk calculators • Lipoprotein(a) measurement recommended at least once in all adults • ApoB helps identify residual lipoprotein risk • Coronary artery calcium scoring refines treatment decisions • LDL-C targets return, with

Wir Triathleten sind doch alle kleine Biohacker. Robin Sorg von Aware weiß, welche Blutwerte wichtig sind – und zeigt anhand der App "Aware", wie diese einfach zu tracken sind.

High cholesterol is one of the most widely discussed—and established—risk factors in medicine. But reams of research now show that while it is key to cardiovascular risk, it is not the whole story.In this episode of A Whole New Level, editorial director Mike Haney sits down with Dr. Ronald Krauss, one of the world's leading lipid researchers and a pioneer in understanding how different forms of LDL—and the physiological factors around them—affect cardiovascular risk.Dr. Krauss explains why the basic link between cholesterol and heart disease is well established among experts—but also why the standard cholesterol panel often misses the deeper metabolic story. Drawing on decades of research, he walks through how lipoproteins, particle size, triglycerides, and metabolic health interact to determine whether cholesterol actually becomes dangerous.Along the way, the conversation explores why cardiovascular disease remains the leading killer despite statins and decades of research—and how factors like obesity, insulin resistance, and inflammation reshape the lipid landscape in ways that traditional tests may not capture.The result is a clearer framework for understanding cardiovascular risk: not just how much cholesterol is in the blood, but how it's being transported, how long those particles circulate, and what metabolic conditions are driving them.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠https://levels.link/wnl⁠⁠In this episode, we coverWhy the cholesterol–heart disease link isn't actually controversial among researchersCholesterol vs. lipoproteins: why the particles carrying cholesterol matter more than the number itselfSmall dense LDL: how triglyceride metabolism produces the most harmful particlesApoB and particle counts: why many researchers prefer measuring particles instead of cholesterol massLipoprotein(a): the genetically driven risk factor affecting up to a third of the populationMetabolic syndrome: the cluster of conditions that amplifies cardiovascular riskWhy carbohydrates and metabolic dysfunction can drive harmful lipid patternsThe saturated fat debate: why food context and metabolic health matter more than simple fat categories

This episode is brought to you by State & Liberty, Caldera Lab, and Strong Coffee Company. Heart disease is still the number one cause of death worldwide, yet most people misunderstand what actually causes cardiovascular disease. In this episode of Ever Forward Radio, we sit down with interventional cardiologist Dr. Christopher Davis, MD to break down the real drivers of heart disease, the role of cholesterol, and why nitric oxide may be one of the most important molecules for cardiovascular health. This masterclass explores the science behind oxidized LDL, endothelial dysfunction, nitric oxide production, inflammation, and environmental toxins — and how these factors silently damage your arteries long before a heart attack occurs. ----- 00:00 – Cardiovascular Disease: The #1 Killer 02:15 – Why Heart Attacks Often Happen Without Severe Blockage 04:50 – The Misunderstanding Around Cholesterol 07:35 – Oxidized LDL and Plaque Formation 10:42 – Lipoprotein(a) and Genetic Risk 13:25 – Environmental Toxins and Cardiovascular Disease 16:10 – Endothelial Dysfunction Explained 19:40 – Nitric Oxide: The Molecule That Regulates Blood Flow 24:15 – Why Nitric Oxide Declines With Age 28:05 – Inflammation and Plaque Rupture 31:30 – The Arginine Paradox 35:12 – Symptoms of Nitric Oxide Deficiency 38:45 – Erectile Dysfunction as a Cardiovascular Warning Sign 42:20 – Mouthwash and Nitric Oxide Suppression 46:18 – Stress, Cortisol, and Arterial Damage 50:05 – Exercise and Nitric Oxide Production 55:40 – Environmental Stressors on the Cardiovascular System 59:10 – Tests That Actually Predict Heart Disease 01:05:30 – Practical Steps to Protect Your Heart ----- Episode resources: Save 15% on men's clothes made for athletic guys with code EVERFORWARD at https://www.StateAndLiberty.com Save 20% on men's skincare with code EVERFORWARD at https://www.CalderaLab.com Save 15% on organic lattes and coffee with code CHASE at https://www.StrongCoffeeCompany.com  Watch and subscribe on YouTube

Join Dr. Kahn for the 4th Reversing Heart Disease Summit beginning March 7, 2026. The event is free to attend online. Register here: drtalks.com/summits/reversing-heart-disease This week, Dr. Kahn reviews new research examining the connection between red meat consumption and the risk of diabetes, elevated cholesterol, and cancer. He also discusses findings from a large study showing that vegetarian diets are associated with a lower risk of several types of cancer.  Additional topics include emerging treatments for Lipoprotein(a), the role of coronary CT angiography in women and in individuals with a family history of heart disease, newly identified predictors of cardiovascular risk in women, dietary patterns that support brain health, and screening strategies to reduce the risk of cardiac arrest in young athletes.  Thanks to Igennus. Visit igennus.com and use the discount code DrKahn for savings on their products.

This week, Dr. Kahn discusses his current health challenge: a leaky mitral valve due to mitral valve prolapse, a condition of unknown cause that is unrelated to lifestyle or diet. He reviews data on mitral valve surgery, comparing repair to replacement, as well as the current availability of robotic surgery and its advantages. He plans to keep the Heart Doc VIP community updated on his status and is feeling great day to day. Short topics this week include wine, olive oil, plant-based diets for breast cancer, Life's Essential 8, the health of babies raised in vegan families, and new data on Lipoprotein(a).  Thanks to Igennus. Use the discount code DRKAHN at igennus.com .

Leslie J Donato. A Turning Point for Lipoprotein(a) Treatment: Are Clinical Laboratories Ready? Clinical Chemistry, Volume 72, Issue 2, February 2026, Pages 222–224. https://doi.org/10.1093/clinchem/hvaf101

When doctors said, “There's nothing more we can do,” LeAnn Wheeler refused to accept that as the final verdict.After multiple procedures, a failed bypass, and being labeled a “no-option” cardiac patient, LeAnn discovered Enhanced External Counterpulsation (EECP) — a non-invasive, FDA-approved, Medicare-covered therapy that has existed for decades but remains largely unknown in the United States.In this powerful conversation, we discuss:• What it feels like to be told you're out of options• The science behind angiogenesis and how the body can grow new blood vessels• Lipoprotein(a) and the hidden genetic risk most patients are never tested for• Why EECP is widely used internationally but underutilized in America• What patients need to know if they're searching for real answersLeAnn now works to bring awareness and access to EECP through Thrive ECP, helping others avoid the devastating moment she experienced.Learn more:https://thriveecp.comThis episode is for anyone navigating heart disease, advocating for a loved one, or questioning whether “no more options” is really the end of the story.

This week, Dr. Kahn breaks down a new paper examining the risks and reported side effects of statins—including the surprising finding that placebo alone is linked to many of the same symptoms. He also covers an oral PCSK9 inhibitor currently under study and what it could mean for cholesterol management. The episode then dives into the latest research on emerging therapies designed to lower lipoprotein(a), including a real-world case study that highlights where this rapidly evolving field is headed.  Shorter discussions include heart disease at a young age, why so many patients fail to reach blood pressure treatment goals, aspirin use one year after AFib ablation, skeletal muscle as an endothelial stabilizer, and why exercise variety may be one of the most powerful risk reducers we have.  Thanks to WellBean for sponsoring the show. Save on their delicious bean-based products at wellbean.life with code DrKahn15.  Dr. Kahn will also be leading a free online seminar on cholesterol on February 17, 2026 at 7 PM EST with Forks Over Knives. Register HERE.

Send us a textDr. H. Jackson Downey sits down with MedEvidence!™ to give the low-down on keeping your lipoprotein(a) numbers down. Lipoprotein little a, also called Lp(a), is a really, really, really, really, really bad cholesterol that is genetically determined, meaning exercise and diet don't help lower the numbers. Instead, Dr. Downey explains, clinical trials are looking into investigational medications for this bad type of cholesterol. Dr. Downey describes the ins and outs of Lp(a) and how clinical research is our best bet for solutions to this dangerous cholesterol.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Weight frustration in perimenopause isn't just about vanity—it's about a physiological shift that changes how our bodies handle fuel. In this episode, Dr. Rachel Pope sits down with midlife health expert Ann Konkoly to demystify GLP-1 medications (like Ozempic and Zepbound), the hidden dangers of visceral fat, and why the scale is often a "shitty measurement" for your actual health.In this episode, we discuss: The "Middle" Mystery: Why the "eat less, move more" mantra fails women in perimenopause and how this transition impacts weight maintenance. GLP-1s Beyond Weight Loss: Ann explains the metabolic benefits of these medications, including reducing neuroinflammation and protecting the heart and kidneys. The Hidden Danger of Visceral Fat: Why a "normal BMI" can be misleading and how internal fat affects your risk for chronic disease. Synergy with MHT: How optimizing cardiovascular health can create a safer "on-ramp" for starting hormone replacement therapy. Preserving Lean Muscle: Strategies for "muscle-centric medicine" to ensure weight loss doesn't come at the expense of your strength and bone density. The HOMA-IR Hack: A simple way to use fasting glucose and insulin levels to see if insulin resistance is your primary roadblock. Planning for your later years: Why the choices you make in your 40s and 50s determine your mobility and independence in your 80s and 90s.The "Proactive Midlife" Lab ChecklistAnn suggests asking your provider for these specific markers to get a true picture of your metabolic health: Fasting Insulin & Fasting Glucose (to calculate your HOMA-IR score). Lipid Panel (focusing on Triglycerides). Lipoprotein(a) & hs-CRP (markers of inflammation and genetic heart risk). Body Composition Analysis (to track muscle mass vs. visceral fat).About Ann:Ann Konkoly is a board-certified Nurse Practitioner, Certified Nurse Midwife, and Menopause Society Certified Practitioner. She is the founder and CEO of Kultivate Women's Health in Beachwood, Ohio, where she specializes in evidence-based hormone therapy, metabolic health, and medical weight management.Connect with Ann: Website: www.kultivatewomenshealth.com/about Instagram: www.instagram.com/annkonkoly.npConnect with Dr. Rachel Pope: Website: ourwomanity.comSocial Media: @drrachelpope

Broadcast from KSQD, Santa Cruz on 1-22-2026: An emailer from Canada asks about long-term Remicade (infliximab) use for her 16-year-old daughter's ulcerative colitis. Dr. Dawn explains the drug blocks tumor necrosis factor, which stops autoimmune attacks but also weakens infection defense—increasing risk of fungal infections, tuberculosis, and after about 10 years, slightly elevated blood cancer risk. She recommends the daughter practice good hygiene and mask in high-risk settings. For achieving full remission, she suggests vitamin D levels around 75-80, DHEA supplementation, strict gluten avoidance due to its pro-inflammatory effects, and working with a certified functional medicine practitioner to heal the gut and potentially withdraw medication. Dr. Dawn presents a case study of a 27-year-old woman with progressive weakness, pins-and-needles sensations, and impaired balance. Despite normal B12 blood levels, elevated homocysteine and methylmalonic acid revealed functional B12 deficiency from using 20-30 nitrous oxide whippets daily. Nitrous oxide oxidizes the cobalt atom in methylcobalamin, permanently inactivating the enzyme needed for myelin sheath maintenance. Treatment requires months of daily B12 injections with recovery taking up to 84 weeks. She warns that nitrous oxide also interacts dangerously with Viagra-type drugs (causing dangerous blood pressure drops), methotrexate, stimulants, hallucinogens, and respiratory depressants. She describes Canadian researchers developing a miniaturized 3D printer for vocal cord repair. After removing nodules that cause hoarseness, the device prints hydrogel along the wound to create a flat surface preventing keloid-like regrowth, rather like spackling a wall before healing occurs underneath. Dr. Dawn discusses lipoprotein(a), written as Lap(a), a genetic cardiovascular risk factor discovered in the 1960s. This relative of LDL carries a protein that promotes blood clots, thus raising heart attack and stroke risks. In a recent large survey, only about 14% of people have been screened despite its significance. New drugs like pelicarsin can reduce Lp(a) levels up to 80%,trials underway to confirm a benefit of reduced cardiac events. She notes tennis star Arthur Ashe had high Lp(a) contributing to his coagulopathy. A natural option is already available. She recommends lumbrokinase, derived from earthworms and used in traditional Chinese medicine, as an existing treatment that combats high Lp(a) and counteracts its procoagulant effects. The product Boluoke is commercially available, offering an alternative to high-dose niacin which causes intolerable flushing and diarrhea. Dr. Dawn reports research finding people with anxiety disorders have 8% lower choline levels in brain regions regulating emotion. Increasing choline could help. Choline sources include eggs (two eggs provide 300mg of the 500mg daily choline need), organ meats, salmon, soybeans, and lecithin supplements.

I was shocked at the comments on this post. Many people, some of them I know to be smart, thought I was nuts for suggesting two middle-aged women who had isolated high LDL-C needn't take meds because their calculated 10-year risk was less than 3% What shocked me is that our guidelines suggest treatment with statins when 10-year risk is ≥ 7.5%. You may not know this but clinicians are supposed to consider cholesterol (and BP) based on overall risk, which include things like age, blood pressure, smoking status as well as HDL. Here is a link to the PCE. It drives me bananas that clinicians don't go over this with patients. They just look at LDL-c in isolation. Content like this comes free of industry support. Please consider becoming a free or paid subscriber.Experts chose this a 7.5% threshold because they felt it was the point where the absolute risk reduction from statins (about 20-25% relative risk reduction) for nonfatal cardiac events outweighed any potential downsides of statins. It is an arbitrary threshold. The thinking: We know from many RCTs that statins reduce future risk by about 20-25% over 5 years. So .25 x the estimated risk outputs the absolute risk reduction. Let's say a person has a calculated risk of 10%. They can expect a 2.5% risk reduction (.25 x 10% = 2.5%) over 10 years. But .25 x 3% = .75, so a person with an estimated risk of 3% who takes a daily pill for 10 years goes to 2.25%. That's not much. Here are some pics of the pushback I recieved:My colleagues rightly point out that atherosclerosis of the coronary arteries is a slow process and longer exposure to lower LDL-c is beneficial. They feel that the 10-year horizon is too short. They cite something called Mendelian randomization studies which find that people who were born with genetic profiles that cause low cholesterol also have low rates of heart attacks. I wrote a post about this. I actually think that statins and blood pressure drugs may have greater effects in younger people who are at lower risk. But come on. Both individuals who I helped calculate risk were below 3%. That's too low to worry about. Further, if you think we treat people with elevated LDL levels who have this low of a risk, why do we need risk calculators? Or…why don't we just treat everyone above a certain age, since age is the largest driver in the calculators? These are issues I spoke with Drs Foy and Murthy about. I learned a ton. I hope you will too. Topics include:* The value of risk calculators* The uncertainty of prediction* The best time window to consider (statin trials were for 5 years; can we assume effect sizes over 5 years are similar at 30 years?) * The causal role of LDL-c vs “metabolic health”* The value of coronary artery calcium testing * Lipoprotein (a) Academic people like to make fun of podcasts, but I can't imagine a more educational 40 minutes. Andrew and Venk are two of the most thoughtful people in cardiology today. Enjoy and consider supporting Sensible Medicine This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I'm a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. In this episode, Dr Warrick Bishop explains the real role of cholesterol in the body and why simple labels like “good” and “bad” cholesterol don't tell the whole story. He breaks down LDL, HDL, triglycerides, and Lipoprotein(a), highlighting how each contributes to understanding cardiovascular risk.

This week on Heart Doc VIP, Dr. Joel Kahn takes a fresh look at niacin (vitamin B3) therapy and its role in managing cholesterol and Lipoprotein(a). He reviews both classic and recent research, explains why many clinicians have moved away from niacin, and then walks through data that suggest it may still have value when used thoughtfully and selectively. Dr. Kahn also shares a real-world case study highlighting how niacin can be effective when carefully monitored. In the episode's shorter segments, Dr. Kahn covers a wide range of timely topics, including the relationship between orange juice and heart disease, the link between uterine fibroids and cardiovascular risk, and why achieving remission from pre-diabetes matters more than ever. He also explores research on polyphenol-rich Tartary buckwheat and its potential connection to slower aging, as well as new findings on statin use and muscle strength.  As always, the episode blends evidence-based medicine with practical insights you can apply to your own heart-health journey.  Sponsor:  Thanks to koyah.com/KAHN10 — check out their excellent product line and save with the code KAHN10.

Commentary by Dr.  Jian'an Wang.

Send us a message with this link, we would love to hear from you. Standard message rates may apply. In this episode of Your Checkup, we break down lipoprotein(a) — a largely inherited form of cholesterol that can significantly increase the risk of heart disease and stroke, even when standard cholesterol numbers look normal. We talk about what Lp(a) is, why it matters, who should be tested, and how it helps explain “unexpected” heart events in otherwise healthy people. While Lp(a) can't currently be lowered with diet or exercise, knowing your level allows you and your care team to be more intentional about prevention by aggressively managing other risk factors like LDL cholesterol, blood pressure, and diabetes. We also discuss what the numbers mean, why most people only need to be tested once, and the promising treatments currently being studied that may change care in the future. References (for Show Notes)Nordestgaard BG, Langsted A. Lipoprotein(a) and Cardiovascular Disease. Lancet. 2024;404(10459):1255-1264.Reyes-Soffer G, et al. AHA Scientific Statement on Lipoprotein(a). Arterioscler Thromb Vasc Biol. 2022;42(1):e48-e60.Di Fusco SA, et al. Lipoprotein(a): Risk Factor and Emerging Target. Heart. 2022;109(1):18-25.Nasrallah N, et al. Lp(a) in Clinical Practice. Eur J Clin Invest. 2025:e70127.Greco A, et al. Lipoprotein(a) as a Pharmacological Target. Circulation. 2025;151(6):400-415.Bess C, Mehta A, Joshi PH. All We Need to Know About Lipoprotein(a). Prog Cardiovasc Dis. 2024;84:27-33.Support the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

This week, Dr. Joel Kahn dives into a timely topic: how cold weather affects heart health. He breaks down why snow shoveling can put extra stress on the heart, what warning signs to watch for, and the simple steps anyone can take to stay safe — especially when the risks can include sudden cardiac events. He also covers a grab-bag of fascinating updates, including new insights on Lipoprotein(a) and blood type, how kimchi may support immune health, what plant-based diets mean for muscle, the link between beer bellies and heart disease, and a look at President Trump's recent heart check-up.  Special thanks to therasage.com — use code DRKAHN20 for discounts on products like the TheraPro Pad, one of Dr. Kahn's go-to wellness tools.

Jeffrey W Meeusen, Xin Yi, Steven W Cotten, Jacob B Nielsen, Leslie J Donato, Patricia M Jones, Alagar R Muthukumar, Rafael Zubirán, Alan T Remaley, Jing Cao, Modern Low-Density Lipoprotein Cholesterol Formulas Outperform Direct Methods in Patients with Hypertriglyceridemia and Low Levels of Low-Density Lipoprotein Cholesterol, Clinical Chemistry, Volume 71, Issue 11, November 2025, Pages 1138–1146, https://doi.org/10.1093/clinchem/hvaf099

Dr. Erin Faules speaks with Dr. Damon Forbes about Lp(a), a genetically influenced lipoprotein linked to cardiovascular disease risk. They discuss how Lp(a) differs from LDL, its role in plaque and clotting, and why a one-time test can help clarify long-term risk. The conversation covers who to screen and when, interpreting Lp(a) alongside apoB and metabolic health, evidence-based ways to lower overall cardiovascular risk, and emerging Lp(a)-lowering therapies

“I think everyone should have Lp(a) measured.”  - Dr. Ann Marie Navar   Key Resources to Go Deeper:  - Dr. Ann Marie Navar  - Lp(a)  - Get a Free Test to Check Your Lp(a) Level   - Previous episode with Dr. Navar about ApoB  About This Episode:  Listen to this replay of an important discussion about Lipoprotein(a), or Lp(a), a critical but often overlooked marker for cardiovascular health. In this episode, host Barbara Hannah Grufferman takes a deep dive with medical expert Dr. Ann Marie Navar from UT Southwestern Medical Center about why this single test could be vital for understanding your heart disease risk, especially if you have a family history of early cardiovascular disease.  Key Topics Covered:  - What Lipoprotein(a) is and how it differs from standard cholesterol measurements  - Why Lp(a) testing is particularly important for certain individuals  - The genetic nature of Lp(a) and its implications for family health  - Current treatment options and promising new therapies on the horizon  - Practical steps for discussing Lp(a) testing with your healthcare provider  Key Takeaways:  - Lp(a) is a distinct type of cholesterol particle not captured in routine lipid panels  - High Lp(a) levels significantly increase risk of heart disease and stroke  - Lp(a) levels are primarily determined by genetics and remain stable throughout life  - Current guidelines recommend universal Lp(a) testing for adults  - New treatments specifically targeting high Lp(a) levels are expected by 2026  - Managing other risk factors can help offset the risk of elevated Lp(a)  - Coronary artery calcium scoring can provide additional risk assessment  Learn More About Dr. Ann Marie Navar  Dr. Navar is a preventive cardiologist and epidemiologist at UT Southwestern Medical Center whose research focuses on cardiovascular disease prevention, risk prediction, and clinical decision-making. She is a leading expert in advanced lipid testing and cardiovascular risk assessment. This is Dr. Navar's second appearance on AGE BETTER, following her previous discussion about the ApoB test, which was one of the most down-loaded episodes in 2024.   Connect With Barbara:  Have ideas for future episodes? We'd love to hear from you!  - Email: agebetterpodcast@gmail.com  - Connect on Instagram HERE  Note: This episode is for informational purposes only and does not constitute medical advice. Please consult with your healthcare provider about your specific situation. Learn more about your ad choices. Visit megaphone.fm/adchoices

I'm excited to share a new AMA episode with you today, dedicated to risk factors specific to women. In this AMA session, I dive into the lifestyle factors that influence lipids, exploring the latest research and discussing Lp(a) and ApoB. Rather than answering your individual questions, I have woven them into the overall outline to create a cohesive and informative conversation. IN THIS EPISODE, YOU WILL LEARN: How women's lifestyle choices directly affect their lipid profiles How knowing if you're a hyper absorber or hyper producer of cholesterol will change your treatment strategy What the Boston Heart Cholesterol Balance test will reveal about your body's ability to handle cholesterol The best treatments for hyper absorbers, and the best treatments for hyper producers How hard plaque differs from soft plaque, and why that matters for women's heart health How the new AI-assisted Clearly scan provides a more complete cardiovascular risk picture than a standard calcium score How chronic stress and elevated cortisol fuel insulin resistance and inflammation, and damage blood vessel linings The benefits of Mediterranean-style eating for improving lipid balance, vasomotor symptoms, and overall metabolic health The importance of managing trauma, stress, and emotional health in midlife How my “n=1” experiment with Zetia and micro-dosed GLP-1s significantly improved my ApoB and inflammation markers Connect with Cynthia Thurlow   Follow on X Instagram LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Resources:  Dietary natural products as emerging lipoprotein(a)-lowering agents The Effects of Menopause Hormone Therapy on Lipid Profile in Postmenopausal Women: A Systematic Review and Meta-Analysis An Update on Lipoprotein(a): The Latest on Testing, Treatment, and Guideline Recommendations

On this episode of the WHOOP Podcast, Emily Capodilupo, WHOOP SVP of Research, Algorithms, and Data, sits down with Dr. Dan Henderson, Primary Care Physician and WHOOP Medical Advisory Board Member, to dive deep into the development and impact of WHOOP Advanced Labs.Emily and Dr. Henderson break down the WHOOP Advanced Labs blood testing panel and how it integrates into your WHOOP data and insights. WHOOP Advanced Labs gives you a more complete picture of your health and this episode dives deeper into the influences of biomarkers like lipoprotein(a), Vitamin D, insulin resistance, and more.Dr. Henderson shares his perspective as a primary care physician on why regular blood testing is important for everyone – not just those experiencing symptoms. Learn how your biomarkers can help optimize your energy, recovery, and longevity to aid symptoms like fatigue, brain fog, and weight fluctuations. (00:39) Meet Dr. Dan Henderson, WHOOP Medical Advisory Board Member(01:02) WHOOP Advanced Labs & The Opportunity in Healthcare(08:38) Why Is Bloodwork Important?: Understanding Your Biomarkers(11:31) Vitamin D: Health Benefits and The Prominence of Deficiency(15:13) Normalizing Fatigue and What It Actually Means For Your Health(21:18) Insulin Resistance: What You Need To Know(25:28) Interpreting Results & Finding Solutions to Symptoms(32:10) Setting New Standards: Why Regular Bloodwork Is Essential(36:50) What is Lipoprotein(a) & What Does It Measure?(39:16) Life Changing Aspects of WHOOP Advanced Labs(42:52) Reaching A Larger Number of Patients with Technological Advancements  (48:29) Key Takeaways For The Audience(50:05) Using WHOOP Labs to Advocate For Care(54:12) Top 5 Symptoms That Can Be Understood with WHOOP Advanced LabsFollow Dr. Dan Henderson:LinkedInSupport the showFollow WHOOP: Sign up for WHOOP Advanced Labs Trial WHOOP for Free www.whoop.com Instagram TikTok YouTube X Facebook LinkedIn Follow Will Ahmed: Instagram X LinkedIn Follow Kristen Holmes: Instagram LinkedIn Follow Emily Capodilupo: LinkedIn

Drs Harrington, Rodriguez, and Ridker discuss the changing field of cardiac prevention, where imaging fits in, and the new concept of standard modifiable risk factor-less patients. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association https://doi.org/10.1161/CIR.0000000000001078 Development and Validation of the American Heart Association's PREVENT Equations https://doi.org/10.1161/CIRCULATIONAHA.123.067626 C-Reactive Protein and Cardiovascular Risk Among Women With No Standard Modifiable Risk Factors: Evaluating the 'Smurf-Less but Inflamed' https://doi.org/10.1093/eurheartj/ehaf658 Mortality in STEMI Patients Without Standard Modifiable Risk Factors: A Sex-Disaggregated Analysis of SWEDEHEART Registry Data https://doi.org/10.1016/S0140-6736(21)00272-5 Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://www.nejm.org/doi/10.1056/NEJMoa2405182 Statins for the 'SMuRFLess But Inflamed': Silent Vascular Inflammation and the Challenge of Translational Science https://doi.org/10.1016/j.jacbts.2025.101318 VERVE-101: A Promising CRISPR-Based Gene Editing Therapy That Reduces LDL-C and PCSK9 Levels in HeFH Patients https://academic.oup.com/ehjcvp/article/10/2/89/7492807 You may also like: Hear John Mandrola, MD, give a summary and his perspective on the top cardiology news each week, on This Week in Cardiology https://www.medscape.com/twic Questions or feedback, please contact news@medscape.net

This week, Dr. Kahn dives into new research linking plant-based diets to both a lower risk of type 2 diabetes and improved control in type 1 diabetes. (Fun fact: even eating one juicy mango a day can help with blood sugar control!) He also tackles the recent Consumer Reports headlines about lead in protein powders, explaining why the use of California's Prop 65 limits may have exaggerated the concern compared to what most health experts believe.  Finally, Dr. Kahn reviews new data on Lipoprotein(a) and heart health—including one fascinating study that connects risk levels to waist size.  This episode is brought to you by the Fresh Pressed Olive Oil Club. Get your discount at getfreshdrkahn.com .

This week, Dr. Joel Kahn explores three advanced methods for cleansing the blood. He begins with apheresis, a medical technique that removes LDL cholesterol and Lipoprotein(a), and discusses new developments in access to this life-saving therapy. Dr. Kahn also breaks down two emerging treatments gaining popularity—EBOO (Extracorporeal Blood Oxygenation and Ozonation) and TPE (Therapeutic Plasma Exchange)—and how they may play a role in improving cardiovascular health. In the second half, Dr. Kahn turns to the topic of cholesterol-lowering therapies like statins, emphasizing how long-term use and individualized risk assessment matter more than online debates suggest. He highlights tools such as the Mayo Clinic Statin Decision Aid, PREVENT calculator, and Astro-CHARM calculator to help patients and practitioners make informed decisions.  Thanks to the Fresh Pressed Olive Oil Club for sponsoring this episode. Visit getfreshdrkahn.com for a special offer.

This week, Dr. Kahn dives into the latest research on how healthy plant-based diets can benefit the body from head to almost toe — including lowering dementia risk, improving sexual health, reducing mortality, and supporting the planet. He also breaks down new studies showing the downsides of even one egg a day, the low testing rates of Lipoprotein(a), and why traditional heart risk factors still matter. Plus, hear how maintaining low cholesterol and heart-healthy habits starting at age 18 can dramatically improve long-term outcomes.  A packed episode filled with practical takeaways for your heart and overall health.

In this episode of The Neuro Experience, I sit down with Dr. Kellyann Niotis—one of the first fellowship-trained preventive neurologists—to reveal how you can protect your brain long before symptoms of Alzheimer's or dementia appear. With Alzheimer's cases expected to triple by 2050, Dr. Niotis explains the difference between dementia types, the real role of genes like ApoE4, and why lifestyle choices may be more powerful than genetics. If you want actionable tools to lower your risk, strengthen your memory, and understand the future of preventive neurology, this conversation delivers science-backed strategies you can start applying today. About Dr. Kellyann Niotis: Dr. Kellyann Niotis is the first fellowship-trained preventive neurologist focused on reducing risk for Alzheimer's, Parkinson's, and Lewy Body Dementia. She launched the nation's first Alzheimer's Prevention Clinic at Weill Cornell and now leads early-detection and brain health research at the Institute for Neurodegenerative Diseases Florida. Her work appears in leading medical journals and has been featured by CNN. *** Subscribe to The Neuro Experience for more conversations at the intersection of brain science and performance. I'm committed to bringing you evidence-based insights that you can apply to your own health journey. *** A huge thank you to my sponsors for supporting this episode:TimelineHead to⁠ http://timeline.com/neuro⁠ to get started. BeamVisit ⁠http://shopbeam.com/TNE⁠ and use code TNE at checkout. Jones Road BeautyHead to ⁠http://Jonesroadbeauty.com⁠ and use code NEURO at checkout. After you purchase, they will ask you where you heard about them. PLEASE support our show and tell them our show sent you. NOCDHead to ⁠http://learn.nocd.com/NEURO⁠ and book a free 15 minute call to get started. Eko HealthGo to ⁠http:/ekohealth.com/NEURO ⁠ for up to $50 off, plus a free chest piece cover.  *** I'm Louisa Nicola — clinical neuroscientist — Alzheimer's prevention specialist — founder of Neuro Athletics. My mission is to translate cutting-edge neuroscience into actionable strategies for cognitive longevity, peak performance, and brain disease prevention. If you're committed to optimizing your brain — reducing Alzheimer's risk — and staying mentally sharp for life, you're in the right place. Stay sharp. Stay informed. Join thousands who subscribe to the Neuro Athletics Newsletter → https://bit.ly/3ewI5P0 Instagram: https://www.instagram.com/louisanicola_/ Twitter : https://twitter.com/louisanicola_ *** Topics discussed: 00:00 – Introduction 01:25 – Preventative neurology 02:23 – Dementia vs. Alzheimer's & Other Types of Dementia 04:08 – What Is Alzheimer's? 05:26 – Clinical Diagnosis: Imaging & Symptoms 07:07 – How Amyloid Disrupts Neural Communication 09:48 – Genetics vs. Lifestyle: Public Misunderstanding 12:02 – Role of Family History & Genetic Risk 14:04 – The ApoE4 Gene Explained15:07 – ApoE Variants 17:08 – ApoE4 and Lipid Transport in the Brain 18:35 – Immune Response & Infection Susceptibility 20:05 – Hormones: Key Role in Brain Health 21:08 – Genotypes & Risk Multipliers 23:01 – ApoE4 Not Always Deterministic: Population Studies 24:15 – Other Genetic Factors Beyond ApoE 25:13 – Biomarkers: Current Use & Limitations 27:13 – Risks of Self-Testing Biomarkers 28:45 – Why Two-Thirds of Patients Are Women 29:46 – Estrogen, Menopause & Neuroprotection 32:07 – Testosterone & Dementia Risk 35:01 – LDL, ApoB & Brain Health Debate 37:01 – Statins & Dementia: Myths vs. Evidence 39:08 – Fear & Misconceptions Around Cholesterol 41:09 – Lipoprotein(a) & Vascular Dementia Risk 44:39 – Brain Vasculature & Hypertension 49:15 – New Alzheimer's Drugs & Risks 55:32 – Why Rates Keep Rising (Lifestyle & Stress) 58:11 – Early Signs 01:00:23 – Tau Protein, Tangles & Neuronal Damage 01:05:49 – Keto vs. Mediterranean 01:07:14 – Personalization & Preference for Mediterranean Diet Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Hoffman continues his conversation with Jim LaValle, a clinical pharmacist and certified clinical nutritionist, detailing cholesterol's importance and its implications for cardiovascular health. 

September is Cholesterol Education Month. In this episode of Intelligent Medicine, Jim LaValle, a clinical pharmacist and certified clinical nutritionist, details cholesterol's importance and its implications for cardiovascular health. He delves into the nuances of cholesterol types, the historical shifts in perceptions of cholesterol, and how dietary and lifestyle factors influence cholesterol levels and cardiovascular risk. Jim provides expert insights into the roles of LDL and HDL cholesterol, the significance of cholesterol particle size, the impact of carbohydrates on cholesterol, and the benefits of aged garlic extract and other supplements. The conversation emphasizes the importance of comprehensive lipid testing, understanding individual risk factors, and integrating both lifestyle modifications and, when necessary, medications into cardiovascular preventive strategies. The episode concludes with a discussion on the role of health policies and the future of integrative health approaches.

This week, Dr. Kahn breaks down the latest guidelines for preventing and treating high blood pressure. He reviews the top 10 lessons from an important new medical article and encourages every listener to own a home blood pressure cuff, use it regularly, and aim for readings under 120/80. Along the way, he also discusses new research on Lipoprotein(a) myths, EMF exposure, cystatin C kidney lab tests, the Fasting Mimicking Diet and its impact on kidney health (prolonlife.com/drkahn), and the role of vitamin C in overall wellness. Thanks to igennus.com for supporting the show, with a special discount available using the code DrKahn.

This week, Dr. Kahn discussed a new paper about the power of a Zero Score Calcium CT Scan in people without symptoms but concerns for soft plaque (non-calcified) in those with symptoms. Generally, patients with symptoms are better tested by Coronary CT Angiograms (CCTA), optimally with FFR and Cleerly Software analysis. He provides case studies from the clinic. Other topics include plant diets for Crohn's Disease prevention, the goal of 7,000 steps a day, Lipoprotein(a) and stroke, heart and brain risk control benefits, strategies to avoid weight gain, and erythritol and heart disease.  Thanks to Igennus.com and the discount code DrKahn.